Vironova
Manufacturing · Sweden · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Gävlegatan 22, Stockholm, Stockholm, 113...Phone Number
+46 87026790Website
www.vironova.comRevenue
$5.5 MillionIndustry
About Vironova
Is Vironova your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Vironova has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Vironova launches new products
Check if Vironova has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Vironova recently announced quarterly report
Check out if Vironova is spiking on competitors!
Click to see if Vironova had a recent Job posting/layoffs
Vironova, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Vironova
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Vironova as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Vironova is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Vironova is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vironova.
Vironova Tech Stack
A closer look at the technologies used by Vironova
Vironova News & Media
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vironova
Vironova focuses on the development of novel antiviral therapeutics and virus identification products to combat and prevent the spread of viral diseases. Based on proprietary software the company also offers image analysis services of nanoparticles that is able to cut time and costs in viral related R&D, drug delivery and production of biologicals.... Read More